Company profile: Inpharmatica
1.1 - Company Overview
Company description
- Provider of predictive informatics in medicinal chemistry and ADME to improve drug discovery, offering Chematica for target selection and druggability assessment, Silico for early ADME optimization via in silico and in vitro assessments, Admensa combining ADME expertise, tools and lab services, secreted protein therapeutics, small molecule programmes, and nicotine solutions for e‑cigarettes.
Products and services
- Chematica: Proprietary chemogenomics platform that architects target selection, performs druggability assessment, and rapidly identifies hits and leads
- Accessible via collaborations, service engagements, or licensing agreements
- Admensa: Integrated ADME optimization assembly combining in silico tools, laboratory services, and expertise to enable early selection of compounds with optimal drug-like properties
- Offered through collaborations, services, or licensing
- Silico: Modular early-ADME optimization service delivering in silico and in vitro assessments plus project support tools from lead discovery to candidate selection
- Available as installed software or fee‑for‑service.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Inpharmatica
DrugDev
HQ: United States
Website
- Description: Provider of cloud-based, technology-driven solutions for clinical trial operations, connecting investigators, sites, sponsors, and CROs. Offerings include DrugDev Spark; Master Data Management using the DrugDev Golden Number; a Clinical Trial Investigator Database; IQVIA Protocol Design; IQVIA StudyOptimizer; and IQVIA GrantPlan for grants budgeting and e-negotiation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full DrugDev company profile →
Faculty Opinions
HQ: United Kingdom
Website
- Description: Provider of a discovery tool for qualitative assessment of published research, leveraging a faculty of over 8,000 leading life science and medicine experts who comment on and validate key publications. Offers H1 Connect for global health opportunities and training, H1 Profile to build credibility and apply, and a WhatsApp community for global peer collaboration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Faculty Opinions company profile →
Kallik
HQ: United Kingdom
Website
- Description: Provider of labeling content management and artwork generation solutions for regulated markets including pharmaceutical, medical devices, cosmetics, and chemicals. Offers Veraciti, a cloud-based system for end-to-end labeling and artwork management with automated artwork generation, asset and phrase management, AI-enabled onboarding and migration, and 24/7 global customer support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kallik company profile →
Metaphore Bio
HQ: United States
Website
- Description: Provider of the MIMIC™ platform, a bioplatform that integrates machine learning and molecular mimicry to engineer therapeutics targeted at specific biological responses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Metaphore Bio company profile →
Gene Logic
HQ: United States
Website
- Description: Provider of comprehensive Genomic Reference Databases and GLP-compliant Microarray Services as part of an integrated genomics offering, serving over two-thirds of the top 25 pharma companies, leading research institutes, and emerging biotech companies worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gene Logic company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Inpharmatica
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Inpharmatica
2.2 - Growth funds investing in similar companies to Inpharmatica
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Inpharmatica
4.2 - Public trading comparable groups for Inpharmatica
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →